David A. Siegel Replimune Group, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 188,400 shares of REPL stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188,400

Previous 209,700 10.16%

Holding current value

$2.12 Million

Previous $1.89 Million 9.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $172,317 - $239,199	-21,300 Reduced 10.16%	188,400 $2.06 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $64,629 - $122,034	-12,900 Reduced 5.8%	209,700 $1.89 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $136,713 - $185,269	19,900 Added 9.82%	222,600 $1.82 Million
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $126,225 - $302,566	-18,700 Reduced 8.45%	202,700 $1.71 Million
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $919,296 - $1.28 Million	-57,600 Reduced 20.65%	221,400 $3.79 Million
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $827,885 - $1.27 Million	52,900 Added 23.4%	279,000 $6.48 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $2 Million - $3.32 Million	114,200 Added 102.06%	226,100 $3.99 Million
Q4 2022 Feb 14, 2023	SELL	$17.09 - $27.91 $184,572 - $301,428	-10,800 Reduced 8.8%	111,900 $3.04 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $195,000 - $264,375	-12,500 Reduced 9.25%	122,700 $2.12 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $795,204 - $1.19 Million	-59,700 Reduced 30.63%	135,200 $2.36 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $1.06 Million - $2.07 Million	69,700 Added 55.67%	194,900 $3.31 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $1.93 Million - $2.6 Million	-75,800 Reduced 37.71%	125,200 $3.39 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $1.42 Million - $1.94 Million	-49,100 Reduced 19.63%	201,000 $5.96 Million
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $1.6 Million - $2.22 Million	-56,300 Reduced 18.37%	250,100 $9.61 Million
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $2.59 Million - $3.9 Million	85,600 Added 38.77%	306,400 $9.35 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $4.29 Million - $9.61 Million	182,600 Added 478.01%	220,800 $8.42 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $720,070 - $1.03 Million	38,200 New	38,200 $879,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $554M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account